Get 50% OFF This Summer!

Advertisement
logo

Medicamen Organics

MEDIORG
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement

Medicamen Organics Share price and Fundamental Analysis

View All Details
View All Details
Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana. Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi.
Company Incorporation1995
ChairmanB K Gupta
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
30.01
PE Ratio
12.51
Industry P/E
35.21
PEG Ratio
0
ROE
10.15%
ROCE
10.94%
ROA
5.65%
Total Debt (Cr)
12.88
Debt to Equity
0.47
Dividend Yield
0%
EPS
2.05
Book Value & P/B
21.99 x 1.17
Face Value
10
Outstanding Shares(Cr)
1.17
Current Ratio
4.73
EV to Sales
1.39

Stock Returns

1 Week-6.04%
1 Month-2.47%
6 Months-52.32%
1 Year-82.27%
3 Years-82.27%
5 Years-82.27%

CAGR

1 Year CAGR

Revenue Growth

+14.11%

Net Profit Growth

+148.02%

Operating Profit Growth

+77.2%

Dividend Growth

N/A

Stock Returns CAGR

-82.27%
no_data

No Stocks

Smart Score

1.8
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 59.73%

FIIs : 0.07%

DIIs : 0.10%

Public : 40.10%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
Promoter Shareholding Increased by 0.03% to 59.73% in March 2025 Qtr
DII Shareholding Increased by 0.03% to 0.1% in March 2025 Qtr
FII Shareholding Decreased by 0.07% to 0.07% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Medicamen Organics Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Medicamen Organics Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana. Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi.

Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer. The Company market product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis.

Further, Company is strategically focusing on establishing a direct presence in international market for an instance in 2023, it directly exported the product in Burundi. These products are marketed across India as well as African, Commonwealth of Independent States (CIS) region and South East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by third-party distributor.

In 1996, the Company started with trading of pharmaceuticals for supplies to various Government departments. During the period 2007, it started construction for own pharma unit at Ranipur, in Haridwar and received WHO/GMP Certificate for Unit I. In 2010, it got license for manufacturing of food supplements, like protein powders, vitamin tablets and syrups etc.

In 2017, it formed a joint venture with Denish Company and gave them authority for worldwide export of Iron Products. The joint venture company, in turn, got 50% equity in the Company. Further, the Company reconstructed Unit-II for production of tablets, capsules, oral liquids, ointments and dry power, veterinary medicines, etc. and got first license for pharma in this unit.

The Company is proposing the Initial Public Offer of 32,00,000 Fresh Issue Equity Shares.

Medicamen Organics Share Price

Medicamen Organics share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Medicamen Organics Market Cap

Market capitalization of Medicamen Organics indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Medicamen Organics is valued compared to its competitors.

Medicamen Organics PE Ratio

Medicamen Organics PE ratio helps investors understand what is the market value of each stock compared to Medicamen Organics 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Medicamen Organics PEG Ratio

The PEG ratio of Medicamen Organics evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Medicamen Organics ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Medicamen Organics generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Medicamen Organics ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Medicamen Organics in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Medicamen Organics Total Debt

Total debt of Medicamen Organics shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Medicamen Organics Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Medicamen Organics compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Medicamen Organics CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Medicamen Organics over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Medicamen Organics Technical Analysis

Technical analysis of Medicamen Organics helps investors get an insight into when they can enter or exit the stock. Key components of Medicamen Organics Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Medicamen Organics shares often struggle to rise above due to selling pressure.

Medicamen Organics Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Medicamen Organics ’s financial health and profitability.

Medicamen Organics Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Medicamen Organics Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Medicamen Organics Financials

The financials of Medicamen Organics provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Medicamen Organics Profit and Loss Statements

The profit and loss statement of Medicamen Organics highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Medicamen Organics .

Medicamen Organics Balance Sheet

The balance sheet presents a snapshot of Medicamen Organics ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Medicamen Organics Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App